Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-FR Version v10-FR
Language French French
Date Updated 2018-10-09 2018-09-20
Drug Identification Number 02392933 02392933
Brand name MYLAN-ATORVASTATIN MYLAN-ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90 BT, 500 BT 90 BT, 500 BT
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2018-10-11 2018-10-01
Actual start date
Estimated end date 2018-10-19 2018-10-30
Actual end date 2018-10-09
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments